Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms

Journal of NeuroVirology

Volumn 15, Issue 5-6, 2009, Pages 425-433

  Fainardi, Enrico ^a   Castellazzi, Massimiliano ^b   Tamborino, Carmine ^b   Seraceni, Silva ^b   Tola, Maria Rosaria ^a   Granieri, Enrico ^b   Contini, Carlo ^b  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Cerebrospinal fluid; Chlamydia pneumoniae; Intrathecal synthesis; Multiple sclerosis; Oligoclonal IgG bands

Indexed keywords

IMMUNOGLOBULIN G; BACTERIUM ANTIBODY; OLIGOCLONAL BAND;

ADULT; ANTIBODY RESPONSE; ARTICLE; CEREBROSPINAL FLUID; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOBLOTTING; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; MALE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELAPSE; REMISSION; ANTIBODY SPECIFICITY; BLOOD; CHLAMYDOPHILA INFECTION; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY;

CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; OLIGOCLONAL BANDS;

EID: 77649112658     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280903475580     Document Type: Article

References (43)

1. Archelos JJ, Hartung HP (2000). Pathogenetic role of auto-antibodies in neurological diseases. Trends Neurosci 23: 317-327.
2. Bagos PG, Nikolopoulos G, Ioannidis A (2006). Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler 12: 397-411.
3. Balin BJ, Gérard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP (1998). Identification and localization of Chlamydia pneumo-niae in the Alzheimer's brain. Med Microbiol Immunol 187: 23-42.
4. Casetta I, Granieri E (2000). Clinical infections and multiple sclerosis: contribution from analytical epidemiology. J NeuroVirol 6(Suppl 2): S147-S151.
5. Chapman MD, Thompson EJ, Candler PM, Dale RC, Church AJ, Giovannoni G (2007). Quantitative demonstration of intrathecal synthesis of high affinity immunoglobulin G in herpes simplex encephalitis using affinity-mediated immunoblotting. J Neuroimmunol 185: 130-135.
6. Conrad AJ, Chiang EY, Andeen LE, Avolio C, Walker SM, Baumhefner RW, Tourtellotte WW (1994). Quantitation of intrathecal measles virus IgG antibody synthesis rate: subacute sclerosing panencephalitis and multiple sclerosis. J Neuroimmunol 54: 99-108.
7. Contini C, Cultrera R, Seraceni S, Castellazzi M, Granieri E, Fainardi E (2004). Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis. Mult Scler 10: 360-369.
8. Contini C, Fainardi E, Seraceni S, Granieri E, Castellazzi M, Cultrera R (2003). Molecular identification and antibody testing of Chlamydophila pneumoniae in a subgroup of patients with HIV-associated dementia complex. Preliminary results. J Neuroimmunol 136: 172-177.
9. Contini C, Seraceni S, Castellazzi M, Granieri E, Fainardi E (2008). Chlamydophila pneumoniae DNA and mRNA transcript levels in peripheral blood mononuclear cells and cerebrospinal fluid of patients with multiple sclerosis. Neurosci Res 62: 58-61.
10. Danesh J, Collins R, Peto R (1997). Chronic infections and coronary heart disease: is there a link? Lancet 350: 430-436.
11. Derfuss T, Gürkov R, Bergh FT, Goebels N, Hartmann M, Barz C, Wilske B, Autenrieth I, Wick M, Hohlfeld R, Meinl E (2001). Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain 124: 1325-1335.
12. Dong-Si T, Weber J, Liu YB, Buhmann C, Bauer H, Bendl C, Schnitzler P, Grond-Ginsbach C, Grau, AJ (2004). Increased prevalence and gene transcription by Chla-mydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis. J Neurol 251: 542-547.
13. Dörries R, Kaiser R, ter Meulen V (1989). Human immunodeficiency virus infection: affinity-mediated immu-noblot detects intrathecal synthesis of oligoclonal IgG specific for individual viral protein. AIDS Res Hum Retroviruses 5: 303-310.
14. Dreses-Werringloer U, Bhuiyan M, Zhao Y, Gérard HC, Whittum-Hudson JA, Hudson AP (2009). Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain. Int J Med Microbiol 299: 187-201.
15. Fainardi E, Contini C, Benassi N, Bedetti A, Castellazzi M, Vaghi L, Govoni V, Paolino, E, Balboni P, Granieri E (2001). Assessment of HIV intrathecal humoral immune response in AIDS-related neurological disorders. J Neu-roimmunol 119: 278-286.
16. Fainardi E, Castellazzi M, Casetta I, Cultrera R, Vaghi L, Granieri E, Contini C (2004). Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms. J Neurol Sci 217: 181-188.
17. Fainardi E, Castellazzi M, Saraceni S, Granieri E, Contini C (2008). Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis. Curr Neurovasc Res 5: 60-70.
18. Franciotta D, Avolio C, Capello E, Lolli F, AINI participating members (2005a). Consensus recommendations of the Italian Association for Neuroimmunology for immu-nochemical cerebrospinal fluid examination. J Neurol Sci 237: 5-11.
19. Franciotta D, Cardini E, Bergamaschi R, Grimaldi LM, Androni L, Cosi V (2005b). Analysis of Chlamydia pneumoniae-specific oligoclonal bands in multiple sclerosis and other neurological diseases. Acta Neurol Scand 112: 238-241.
20. Gérard HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C, Balin BJ, Frey WH 2nd, Bordayo EZ, Whittum-Hudson JA, Hudson AP (2006). Chlamydo-phila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunol Med Microbiol 48: 355-366.
21. Gilden DH (2005). Infectious causes of multiple sclerosis. Lancet Neurol 4: 195-202.
22. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Strandness ED, Wang SP (1995). Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 92: 3397-3400.
23. Hauser SL, Oksenberg JR (2006). The neurobiology of multiple sclerosis: genes, inflammation, and neurode-generation. Neuron 52: 61-76.
24. Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley DPE, Moseley IF, Rudge P, McDonald WI (1990). Breakdown of blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain 113: 1477-1489.
25. Krametter D, Niederwieser G, Berghold A, Birnbaum G, Strasser-Fuchs S, Hartung HP, Archelos JJ (2001). Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker. Mult Scler 7: 13-18. (Pubitemid 32396573)
26. Krüll M, Kramp J, Petrov T, Klucken AC, Hocke AC, Walter C, Schmeck B, Seybold J, Maass M, Ludwig S, Kuipers JG, Suttorp N, Hippenstiel S (2004). Differences in cell activation by Chlamydophila pneumoniae and Chlamydia trachomatis infection in human endothelial cells. Infect Immun 72: 6615-6621.
27. Kurtzke JF (1983). Rating neurological impairment in multiple sclerosis: an expanded disability scale (EDSS). Neurology 33: 1444-1452.
28. Lipton HL, Liang Z, Hertzler S, Son K-N (2007). A specific viral cause of multiple sclerosis: one virus, one disease. Ann Neurol 61: 514-523.
29. Lublin DF, Reingold SC 1996. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46: 907-911.
30. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001). Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50: 121-127.
31. Mukhopadhyay S, Clark AP, Sullivan EsD, Miller RDRD, Summersgill JT (2004). Detailed protocol for purification of Chlamydia pneumoniae elementary bodies. J Clin Microbiol 42: 3288-3290.
32. Pachner AR, Li L, Narayan K (2007). Intrathecal antibody production in an animal model of multiple sclerosis. J Neuroimmunol 185: 57-63.
33. Poser CM, Paty DW, Scheimberger L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983). New diagnostic criteria for MS: guidelines for research protocols. Ann Neurol 13: 227-231.
34. Reiber H, Lange P (1991). Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 37: 1153-1160.
35. Reiber H, Ungefehr S, Jacobi C (1998). The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 4: 111-117.
36. Rostasy K, Reiber H, Pohl D, Lange P, Ohlenbusch A, Eiffert H, Maass M, Hanefeld F (2003). Chlamydia pneumoniae in children with MS. Frequency and quantity of intrathecal antibodies. Neurology 61: 125-128.
37. Salden HJM, Bas BM, Hermas JT, Janson PC (1988). Analytical performance of the three commercially available nephelometers compared quantifying protein in serum and cerebrospinal fluid. Clin Chem 34: 1594-1596.
38. Smith-Jensen T, Burgoon MP, Anthony J, Kraus H, Gilden DH, Owens GP (2000). Comparison of immuno-globulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response. Neurology 54: 1227-1232.
39. Sommer K, Njau F, Wittkop U, Thalmann J, Bartling G, Wagner A, Klos A (2009). Identification of high- and low-virulent strains of Chlamydia pneumoniae by their characterization in a mouse pneumonia model. FEMS Immunol Med Microbiol 55: 206-214.
40. Sriram S, Stratton CW, Yao SY, Tharp A, Ding L, Bannan JD, Mitchell WM (1999). Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 46: 6-14.
41. Tibbling G, Link H, Ohman S (1977). Principles of albumin and IgG analyses in neurological disorders: I. Establishment of reference value. Scand J Clin Lab Invest; 37: 385-390.
42. Thompson EJ (2004). Quality versus quantity: which is better for cerebrospinal fluid IgG? Clin Chem 50: 1721-1722.
43. Yao SY, Stratton CW, Mitchell WM, Sriram S (2001). CSF oligoclonal bands in MS include antibodies against Chlamydiophila antigens. Neurology 56: 1168-1176.